1-20 of 34
infusion procedures
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome

Clinical Trials & Observations
Andrew B. Song, Rahul Sakhuja, Nancy M. Gracin, Ronald Weinger, Raj S. Kasthuri, Hanny Al-Samkari
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3850–3854.
https://doi.org/10.1182/bloodadvances.2021004810
Published: 2021
Journal Articles

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Clinical Trials & Observations
Susanne Jung, Jochen Greiner, Stephanie von Harsdorf, Pavle Popovic, Roland Moll, Jens Schittenhelm, Kosmas Kandilaris, Volker Daniel, Alexander Kunz, Michael Schmitt, Peter Dreger
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3789–3793.
https://doi.org/10.1182/bloodadvances.2021004889
Published: 2021
Includes: Supplemental data
Journal Articles

Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells

Clinical Trials & Observations
Martina Pennisi, Miriam Sanchez-Escamilla, Jessica R. Flynn, Roni Shouval, Ana Alarcon Tomas, Mari Lynn Silverberg, Connie Batlevi, Renier J. Brentjens, Parastoo B. Dahi, Sean M. Devlin, Claudia Diamonte, Sergio Giralt, Elizabeth F. Halton, Tania Jain, Molly Maloy, Elena Mead, Maria Lia Palomba, Josel Ruiz, Bianca Santomasso, Craig S. Sauter, Michael Scordo, Gunjan L. Shah, Jae H. Park, Lucrecia Yanez San Segundo, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3397–3406.
https://doi.org/10.1182/bloodadvances.2020003885
Published: 2021
Includes: Supplemental data
Journal Articles

Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Donald L. Patrick, Annette Powers, Monika Parisi Jun, Yeonhee Kim, Jacob Garcia, Christine Dehner, David G. Maloney
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2245–2255.
https://doi.org/10.1182/bloodadvances.2020003503
Published: 2021
Includes: Supplemental data
Journal Articles

Absolute lymphocyte count proliferation kinetics after CAR T-cell infusion impact response and relapse

Clinical Trials & Observations
Sophia Faude, Jane Wei, Kavitha Muralidharan, Xiaoming Xu, Gerald Wertheim, Michele Paessler, Vijay G. Bhoj, Stephan A. Grupp, Shannon L. Maude, Susan R. Rheingold, Vinodh Pillai
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2128–2136.
https://doi.org/10.1182/bloodadvances.2020004038
Published: 2021
Includes: Supplemental data
Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Clinical Trials & Observations
Antonio Pierini, Loredana Ruggeri, Alessandra Carotti, Franca Falzetti, Simonetta Saldi, Adelmo Terenzi, Claudio Zucchetti, Gianluca Ingrosso, Tiziana Zei, Roberta Iacucci Ostini, Sara Piccinelli, Samanta Bonato, Sara Tricarico, Antonella Mancusi, Sara Ciardelli, Roberto Limongello, Mara Merluzzi, Mauro Di Ianni, Rita Tognellini, Olivia Minelli, Cristina Mecucci, Maria Paola Martelli, Brunangelo Falini, Massimo Fabrizio Martelli, Cynthia Aristei, Andrea Velardi
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1199–1208.
https://doi.org/10.1182/bloodadvances.2020003739
Published: 2021
Includes: Supplemental data
Journal Articles

Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma

Clinical Trials & Observations
Panayiotis Panayiotidis, George A. Follows, Luigina Mollica, Arnon Nagler, Muhit Özcan, Armando Santoro, Don Stevens, David Trevarthen, Florian Hiemeyer, Jose Garcia-Vargas, Barrett H. Childs, Pier Luigi Zinzani, Martin Dreyling
Journal: Blood Advances
Blood Adv (2021) 5 (3): 823–828.
https://doi.org/10.1182/bloodadvances.2020002910
Published: 2021
Includes: Supplemental data
Journal Articles

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Clinical Trials & Observations
Wen-Kai Weng, Sally Arai, Andrew Rezvani, Laura Johnston, Robert Lowsky, David Miklos, Judith Shizuru, Lori Muffly, Everett Meyer, Robert S. Negrin, Erica Wang, Timothy Almazan, Lynn Million, Michael Khodadoust, Shufeng Li, Richard T. Hoppe, Youn H. Kim
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4474–4482.
https://doi.org/10.1182/bloodadvances.2020001627
Published: 2020
Journal Articles

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Clinical Trials & Observations
Tadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, Vasile Musteata, Jacek Treliński, Nichola Cooper, Peter Kiessling, Ute Massow, Franz Woltering, Rose Snipes, Juan Ke, Grant Langdon, James B. Bussel, Stephen Jolles
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4136–4146.
https://doi.org/10.1182/bloodadvances.2020002003
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Paolo Strati, Loretta J. Nastoupil, Jason Westin, Luis E. Fayad, Sairah Ahmed, Nathan H. Fowler, Fredrick B. Hagemeister, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Sherry Adkins, Catherine M. Claussen, Charles S. Martinez, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, Haleigh E. Mistry, Sandra Horowitz, Shirley George, Lei Feng, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Sudhakar Tummala, T. Linda Chi
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3943–3951.
https://doi.org/10.1182/bloodadvances.2020002228
Published: 2020
Journal Articles

Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

Clinical Trials & Observations
Tania Jain, Andrea Knezevic, Martina Pennisi, Yunxin Chen, Josel D. Ruiz, Terence J. Purdon, Sean M. Devlin, Melody Smith, Gunjan L. Shah, Elizabeth Halton, Claudia Diamonte, Michael Scordo, Craig S. Sauter, Elena Mead, Bianca D. Santomasso, M. Lia Palomba, Connie W. Batlevi, Molly A. Maloy, Sergio Giralt, Eric Smith, Renier Brentjens, Jae H. Park, Miguel-Angel Perales, Sham Mailankody
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3776–3787.
https://doi.org/10.1182/bloodadvances.2020002509
Published: 2020
Includes: Supplemental data
Journal Articles

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Paolo Strati, Penny Fang, Misha C. Hawkins, Sherry Adkins, Jason Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphael E. Steiner, Swaminathan P. Iyer, M. Alma Rodriguez, Michael Wang, Christopher Flowers, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2871–2883.
https://doi.org/10.1182/bloodadvances.2020001837
Published: 2020
Journal Articles

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Clinical Trials & Observations
Je-Hwan Lee, Stefan Faderl, John M. Pagel, Chul Won Jung, Sung-Soo Yoon, Animesh D. Pardanani, Pamela S. Becker, Howard Lee, Jeongeun Choi, Kyoungjune Lee, Minkyoung Kim, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2032–2043.
https://doi.org/10.1182/bloodadvances.2019000757
Published: 2020
Includes: Supplemental data
Journal Articles

IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer

Scott N. Furlan, Karnail Singh, Christina Lopez, Victor Tkachev, Daniel Joel Hunt, James Hibbard, Kayla M. Betz, Bruce R. Blazar, Cole Trapnell, Leslie S. Kean
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1594–1605.
https://doi.org/10.1182/bloodadvances.2019001248
Published: 2020
Includes: Supplemental data
Journal Articles

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

Clinical Trials & Observations
Stephen J. Schuster, Richard T. Maziarz, Elisha S. Rusch, Junlong Li, James E. Signorovitch, Vadim V. Romanov, Frederick L. Locke, David G. Maloney
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1432–1439.
https://doi.org/10.1182/bloodadvances.2019001304
Published: 2020
Includes: Supplemental data
Journal Articles

Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Richard T. Maziarz, Edmund K. Waller, Ulrich Jaeger, Isabelle Fleury, Joseph McGuirk, Harald Holte, Samantha Jaglowski, Stephen J. Schuster, Michael R. Bishop, Jason R. Westin, Stephan Mielke, Takanori Teshima, Veronika Bachanova, Stephen R. Foley, Peter Borchmann, Gilles A. Salles, Jie Zhang, Ranjan Tiwari, Lida B. Pacaud, Qiufei Ma, Constantine S. Tam
Journal: Blood Advances
Blood Adv (2020) 4 (4): 629–637.
https://doi.org/10.1182/bloodadvances.2019001026
Published: 2020
Includes: Supplemental data
Journal Articles

Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia

Clinical Trials & Observations
Nitin Jain, Wendy Stock, Amer Zeidan, Ehab Atallah, James McCloskey, Leonard Heffner, Benjamin Tomlinson, Bhavana Bhatnagar, Jay Feingold, David Ungar, Grace Chao, Xiaoyan Zhang, Yajuan Qin, Karin Havenith, Hagop Kantarjian, Matthew J. Wieduwilt
Journal: Blood Advances
Blood Adv (2020) 4 (3): 449–457.
https://doi.org/10.1182/bloodadvances.2019000767
Published: 2020
Includes: Supplemental data
Journal Articles

The severe spontaneous bleeding phenotype in a novel hemophilia A rat model is rescued by platelet FVIII expression

Qizhen Shi, Jeremy G. Mattson, Scot A. Fahs, Aron M. Geurts, Hartmut Weiler, Robert R. Montgomery
Journal: Blood Advances
Blood Adv (2020) 4 (1): 55–65.
https://doi.org/10.1182/bloodadvances.2019000944
Published: 2020
Journal Articles

“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients

Clinical Trials & Observations
Ifigeneia Tzannou, Ayumi Watanabe, Swati Naik, Rachel Daum, Manik Kuvalekar, Kathryn S. Leung, Caridad Martinez, Ghadir Sasa, Mengfen Wu, Adrian P. Gee, Robert A. Krance, Stephen Gottschalk, Helen E. Heslop, Bilal Omer
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2571–2580.
https://doi.org/10.1182/bloodadvances.2019000371
Published: 2019
Includes: Supplemental data
Journal Articles

Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion

Clinical Trials & Observations
Michael R. Bishop, Richard T. Maziarz, Edmund K. Waller, Ulrich Jäger, Jason R. Westin, Joseph P. McGuirk, Isabelle Fleury, Harald Holte, Peter Borchmann, Christopher del Corral, Ranjan Tiwari, Özlem Anak, Rakesh Awasthi, Lida Pacaud, Vadim V. Romanov, Stephen J. Schuster
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2230–2236.
https://doi.org/10.1182/bloodadvances.2019000151
Published: 2019